01349 復旦張江
公司資料 - 財務比率
上海復旦張江生物醫藥股份有限公司 股票編號: 01349
SHANGHAI FUDAN-ZHANGJIANG BIO-PHARMACEUTICAL CO. LTD. 集團網址: http://www.fd-zj.com
盈利能力分析
2024/12 2023/12 2022/12 2021/12 2020/12
資產回報率 (%)1.455%3.712%4.794%8.077%8.100%
股東資金回報率 (%)1.705%4.708%6.202%10.148%11.192%
資本運用回報率 (%)1.701%4.580%5.993%9.467%7.944%
 
邊際利潤分析
毛利率 (%)----------
未計利息、稅項、折舊及攤銷前利潤率 (%)15.675%21.111%21.926%24.138%28.099%
稅前邊際利潤率 (%)0.769%11.464%12.830%18.935%21.192%
純利率 (%)5.601%12.769%13.383%18.705%19.748%
 
變現能力分析
流動比率 (X)6.403 X3.702 X3.073 X3.650 X4.736 X
速動比率 (X)6.214 X3.615 X3.013 X3.583 X4.652 X
 
財務槓桿分析
總負債 / 總資產比率 (%)10.873%18.011%24.294%21.271%19.683%
總負債 / 股東資金比率 (%)12.203%21.977%32.032%26.977%24.477%
非流動負債 / 股東資金比率 (%)1.314%0.556%2.199%2.890%3.197%
利息盈利率 (倍)10.225 X32.807 X87.002 X205.636 X32.548 X
 
營運效率分析
存貨周轉率日數 (日)23.389 Day(s)18.058 Day(s)13.478 Day(s)11.465 Day(s)14.857 Day(s)
 

Copyright © 2025 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.